Gemcitabine, Carboplatin, and Lenalidomide for Treatment of Advanced/Metastatic Urothelial Cancer and Other Solid Tumors
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Seagen Inc.
Merck Sharp & Dohme LLC
Incyte Corporation
Jiangsu HengRui Medicine Co., Ltd.
Universitaire Ziekenhuizen KU Leuven
NGM Biopharmaceuticals, Inc
Esperas Pharma Inc.
EpicentRx, Inc.
Cyteir Therapeutics, Inc.
Mayo Clinic
Eli Lilly and Company
Grupo Español de Investigación en Cáncer de Ovario
Astex Pharmaceuticals, Inc.
City of Hope Medical Center
AstraZeneca
Eastern Cooperative Oncology Group
pharmaand GmbH
Cedars-Sinai Medical Center
University of California, San Diego
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Sotio Biotech Inc.
University of Virginia
AB Science
Barbara Ann Karmanos Cancer Institute
AstraZeneca
University of Maryland, Baltimore
Eli Lilly and Company
GOG Foundation
GOG Foundation
GOG Foundation
National Cancer Institute (NCI)
University of Chicago
Sotio Biotech Inc.
City of Hope Medical Center
GOG Foundation
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
University of Southern California
Genentech, Inc.
GlaxoSmithKline
Hoffmann-La Roche
GOG Foundation
Altor BioScience
NewVac LLC
AGO Study Group
AGO Study Group
Memorial Sloan Kettering Cancer Center
Professor Fernando Figueira Integral Medicine Institute
Boehringer Ingelheim